Peter Thiel-Backed Psychedelic Firm Atai Sets Terms For US IPO, Sees $2.3B Valuation

  • Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, has announced terms for its initial public offering. 
  • See the SEC prospectus here.
  • The German company said it was looking to raise around $214.3 million through a U.S. IPO, targeting a valuation of about $2.3 billion.
  • The biotech startup, which explores the …

Full story available on Benzinga.com

More Peter Thiel-Backed Psychedelic Firm Atai Sets Terms For US IPO, Sees $2.3B Valuation